We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLKM:IDXPT Telkom Indonesia (Persero) Tbk Class B Analysis

Data as of 2026-03-14 - not real-time

IDR 2,970.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

TLKM is currently trading well below its 20‑day and 50‑day moving averages, sitting just above a identified support zone. The RSI reading sits in oversold territory, while the MACD remains in a bearish configuration, indicating short‑term downside pressure. Nevertheless, daily volume has been on the rise, suggesting accumulating buyer interest. On the fundamentals side, the company posts strong gross and operating margins and delivers an ROE that outperforms many peers. Its price‑to‑earnings multiple is comfortably under the sector average and the dividend yield remains among the highest in the market.
Analyst consensus is bullish, with price targets positioned near the upper end of the 52‑week range, implying a sizable upside from current levels. The discounted cash‑flow valuation also points to a meaningful margin of safety. However, a payout ratio approaching 100 % and a moderate debt‑to‑equity ratio raise questions about dividend sustainability. The stock’s recent volatility and a historical drawdown of nearly a quarter add a layer of risk, though its low beta tempers market‑wide swings. Overall, the blend of attractive valuation, robust cash generation, and defensive sector exposure supports a buy stance for medium‑to‑long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support
  • oversold RSI
  • rising volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued relative to peers
  • strong cash flow generation
  • high dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • strategic infrastructure spinoff potential
  • stable earnings and margins
  • defensive telecom sector

Key Metrics & Analysis

Financial Health

Revenue Growth-0.90%
Profit Margin14.77%
P/E Ratio13.5
ROE18.31%
ROA8.31%
Debt/Equity50.11
P/B Ratio2.1
Op. Cash FlowIDR65250.0B
Free Cash FlowIDR28141.6B
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI31.0
SupportIDR 2,920.00
ResistanceIDR 3,660.00
MA 20IDR 3,349.00
MA 50IDR 3,467.20
MA 200IDR 3,208.70
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueIDR 3,407.84
Target PriceIDR 3,887.27
Upside/Downside30.88%
GradeUndervalued
TypeBlend
Dividend Yield7.15%

Risk Assessment

Beta0.22
Volatility40.94%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.